Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study

Randomized Controlled Trial

. 2015 Jun;101(6):1188-96.

doi: 10.3945/ajcn.114.103531. Epub 2015 Apr 29.

Affiliations

PMID: 25926507
DOI: 10.3945/ajcn.114.103531

Free article

Randomized Controlled Trial

Lillian Jespersen et al. Am J Clin Nutr. 2015 Jun.

Free article

Abstract

Background: Probiotics can modulate the immune system in healthy individuals and may help reduce symptoms related to respiratory infections.

Objective: The objective of the study was to investigate the effect of the probiotic strain Lactobacillus paracasei subsp. paracasei, L. casei 431 (Chr. Hansen A/S) (hereafter, L. casei 431) on immune response to influenza vaccination and respiratory symptoms in healthy adults.

Design: A randomized double-blind, placebo-controlled trial was conducted in 1104 healthy subjects aged 18-60 y at 2 centers in Germany and Denmark. Subjects were randomly assigned to receive an acidified milk drink containing ≥10(9) colony-forming units of L. casei 431 (n = 553) or placebo (n = 551) for 42 d. After 21 d, subjects received the seasonal influenza vaccination. The primary outcome was seroprotection rate (anti-influenza antibody titers by hemagglutination inhibition) 21 d after vaccination. Other outcomes were seroconversion rate and mean titers, influenza A-specific antibodies and incidence, and duration and severity of upper respiratory symptoms. Antibiotic use and use of health care resources were recorded.

Results: There was no effect of L. casei 431 on immune responses to influenza vaccination. Generalized linear mixed modeling showed a shorter duration of upper respiratory symptoms in the probiotic group than in the placebo group (mean ± SD: 6.4 ± 6.1 vs. 7.3 ± 9.7 d, P = 0.0059) in the last 3 wk of the intervention period. No statistically significant differences were found for incidence or severity.

Conclusions: Daily consumption of L. casei 431 resulted in no observable effect on the components of the immune response to influenza vaccination but reduced the duration of upper respiratory symptoms. The trial was registered at www.isrctn.com as ISRCTN08280229.

Keywords: L. casei 431; Lactobacillus paracasei subsp. paracasei; immune function; probiotics; upper respiratory tract infection; vaccination response.

PubMed Disclaimer

Cited by

Intestinal Klebsiella pneumoniae Contributes to Pneumonia by Synthesizing Glutamine in Multiple Myeloma.
Wang Y, Yang Q, Zhu Y, Jian X, Guo J, Zhang J, Kuang C, Feng X, An G, Qiu L, Li G, He Y, Zhou W. Wang Y, et al. Cancers (Basel). 2022 Aug 29;14(17):4188. doi: 10.3390/cancers14174188. Cancers (Basel). 2022. PMID: 36077725 Free PMC article.
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases.
van den Elsen LW, Poyntz HC, Weyrich LS, Young W, Forbes-Blom EE. van den Elsen LW, et al. Clin Transl Immunology. 2017 Jan 20;6(1):e125. doi: 10.1038/cti.2016.91. eCollection 2017 Jan. Clin Transl Immunology. 2017. PMID: 28197336 Free PMC article. Review.
Review article: Probiotics, prebiotics and dietary approaches during COVID-19 pandemic.
Hu J, Zhang L, Lin W, Tang W, Chan FKL, Ng SC. Hu J, et al. Trends Food Sci Technol. 2021 Feb;108:187-196. doi: 10.1016/j.tifs.2020.12.009. Epub 2020 Dec 14. Trends Food Sci Technol. 2021. PMID: 33519087 Free PMC article. Review.
Microbiota and the Response to Vaccines Against Respiratory Virus.
Gonçalves JIB, Borges TJ, de Souza APD. Gonçalves JIB, et al. Front Immunol. 2022 May 6;13:889945. doi: 10.3389/fimmu.2022.889945. eCollection 2022. Front Immunol. 2022. PMID: 35603203 Free PMC article. Review.
Sustainable Design of Innovative Kiwi Byproducts-Based Ingredients Containing Probiotics.
Ilie GI, Milea ȘA, Râpeanu G, Cîrciumaru A, Stănciuc N. Ilie GI, et al. Foods. 2022 Aug 5;11(15):2334. doi: 10.3390/foods11152334. Foods. 2022. PMID: 35954100 Free PMC article.

Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study - PubMed (original) (raw)